GlassScriptPhysician profile
Swatee Mohapatra
NPI 1588868186
$4,846.58
in general payments reported to CMS, 2019-2025
38 companies · $1,117 in 2025
The $1,117 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $203 · 2021: $480 · 2022: $986 · 2023: $842 · 2024: $1,219 · 2025: $1,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,177.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $945.56 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $712.43 | 2020-2025 | Ubrelvy, Qulipta, Synthroid |
| Lilly USA, LLC | $419.29 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $407.42 | 2021-2025 | Jardiance, Ofev |
| Astrazeneca Pharmaceuticals LP | $342.54 | 2021-2024 | Airsupra, Farxiga, Breztri |
| Amarin Pharma, INC. | $271.53 | 2020-2023 | |
| Glaxosmithkline, LLC. | $200.85 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Dexcom, INC. | $195.61 | 2024-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $155.62 | 2021-2025 | |
| Pfizer INC. | $136.10 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $118.24 | 2021-2024 | Spravato |
| Amgen INC. | $91.66 | 2024-2025 | Repatha, Otezla, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $81.77 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $66.08 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $61.91 | 2024-2025 | Voquezna |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $61.73 | 2023-2025 | Azmiro, Horizant, Horizant |
| Nevro Corp. | $48.90 | 2023-2024 | Senza |
| Merck Sharp & Dohme LLC | $46.03 | 2021-2025 | Gardasil 9, Capvaxive |
| Antares Pharma, INC. | $45.97 | 2022-2023 | Tlando, Xyosted, Nocdurna |
| Seqirus USA INC | $42.36 | 2025 | Fluad, Flucelvax |
| Sanofi-Aventis U.S. LLC | $33.40 | 2020-2022 | |
| Esperion Therapeutics, INC. | $30.50 | 2024-2025 | Nexletol |
| Coloplast Corp | $29.55 | 2021 | |
| Inspire Medical Systems, INC. | $28.78 | 2025 | Inspire |
| Inari Medical, INC. | $25.56 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Exact Sciences Corporation | $24.62 | 2024 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $22.74 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Madrigal Pharmaceuticals | $22.70 | 2025 | Rezdiffra |
| Abbott Laboratories | $21.93 | 2022 | |
| Dynavax Technologies Corporation | $21.35 | 2023 | Heplisav-B |
| Philips North America LLC | $20.63 | 2024 | (Ck7) Extended Holter |
| Nestle Healthcare Nutrition INC. | $20.30 | 2021 | |
| Medtronic, INC. | $19.25 | 2025 | Inceptiv |
| Alk-Abello, INC | $18.67 | 2023 | Grastek, Ragwitek, Odactra |
| Halozyme INC | $14.14 | 2023 | |
| Aimmune Therapeutics, INC. | $14.08 | 2024 | |
| Alfasigma USA, INC. | $13.79 | 2021 | |
| Orthofix Medical, INC. | $12.99 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swatee Mohapatra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.